And NCI axes clinical trial funding for children with brain tumors

August 26, 2025 Check out STAT+

Sponsored By

Adobe HHS terminates NIH program aimed at diversifying biomedical workforce Grant applications for the program, seen at odds with President Trump's ban on DEI efforts, had previously fallen out of favor. By Veronica Paulus As MAHA turns 1, a fired-up movement is still figuring out how to fulfill its promises One year after exploding on the scene, RFK Jr.'s Make America Healthy Again movement faces both growing influence and difficulty enacting its plans. By Isabella Cueto Opinion: We surveyed hundreds of biomedical researchers about the instability in federal funding. Here's what they said We surveyed hundreds of biomedical researchers about how they are affected by instability in federal funding. They are devastated. By Arghavan Salles, Tiffany Do, and Emily Mastej Adobe STAT+ | Major U.S. drug manufacturing plant did not properly investigate cat hair, pests, and other problems, FDA finds The Indiana plant, once owned by Catalent and now owned by Novo Nordisk, is widely used by the pharmaceutical industry. By Ed Silverman and Elaine Chen

More around STAT

---

In case you missed it NCI axes funding for pediatric brain cancer trial consortium, shifts focus to broader oncology group, Fierce Biotech MD Anderson researcher accused of stealing cancer data, trying to take it to China, Houston Chronicle AbbVie to buy Gilgamesh's psychedelic drug for up to $1.2 billion, STAT First Opinion: Testosterone made me feel 30 again — until it nearly broke my heart, STAT

---

Check out more exclusive coverage with a STAT+ subscription Read premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.

---

Enjoying Cancer Briefing? Tell us about your experience Continue reading the latest health & science news with the STAT app Download on the App Store or get it on Google Play

STAT, 1 Exchange Place, Boston, MA ©2025, All Rights Reserved. I no longer wish to receive STAT emails

Update Newsletter Preferences     •    Contact Us     •    Advertise with Us     •    View in Browser